MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The effect and mechanism of acupuncture for pain in Parkinson’s disease

    S.-W. Yu, Y.-R. Wu, J.-J. Wang, C.-C. Tsai (Taoyuan, Taiwan)

    Objective: We aim to investigate the effect and mechanism of acupuncture in Parkinson’s disease (PD) patient with pain. Background: Acupuncture has been popularly practiced among…
  • 2017 International Congress

    An auditory biomarker for Parkinson’s Disease ?

    K. De Keyser, A. Bockstael, D. Botteldooren, D. Talsma, M. De Letter, P. Santens (Ghent, Belgium)

    Objective: In this preliminary study we aimed to investigate the nature of the differences in auditory function between patients with PD (N=25 with Hoehn and…
  • 2017 International Congress

    Long-term levodopa therapy accelerates the circadian rhythm dysfunction in 6-OHDA rat model

    D. Lv, Y. Wang, F. Wang, X. Zhang, X. Gu, Y. Yang (Suzhou, China)

    Objective: We aimed to study the effect of L-DOPA on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • 2017 International Congress

    Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

    N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. Qamar, K.R. Chaudhuri (Moscow, Russian Federation)

    Objective: To describe clinical and imaging biomarkers of nonmotor symptoms burden (NMSB) as defined by NMS questionnaire (NMSQ) scores in a prospective international cohort study…
  • 2017 International Congress

    Vmat2 heterozygote mice display motor dysfunction and progressive depressive-like behaviors

    K. Ma, J. Huang, L. Liu, C. Han, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To assess motor and depressive behaviors in mice that are heterozygous for VMAT2 (VMAT2 HT). Background: Dopamine (DA) is compartmentalized by the vesicular monoamine…
  • 2017 International Congress

    Association of nocturnal stridor with clinical features of patients with multiple system atrophy

    H.-S. Ryu, J.-H. Paek, S. You, M.-J. Kim, Y.J. Kim, J. Kim, K. Kim, S.-A. Lee, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association between findings of night video-polysomnography and clinical feature of patients with multiple system atrophy (MSA). Background: Nocturnal sleep-related clinical sympotoms…
  • 2017 International Congress

    Mutational analysis of COQ2 in Chinese patients with multiple-system atrophy

    J. Zhang, Y. Hao, Y. Chen, M. Ding, X. Zhang, W. Gu (Beijing, China)

    Objective: To investigate the involvement of COQ2 variants in Chinese sporadic cases with multiple-system atrophy. Background: Multiple-system atrophy (MSA) is a rapidly progressive neurodegenerative disease…
  • 2017 International Congress

    Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy

    M. Jecmenica Lukic, T. Pekmezovic, I. Petrovic, A. Tomic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: The aim of this study was to determine the neuropsychiatric profile in our cohort of PSP patients and their dynamic changes over a follow-up…
  • 2017 International Congress

    Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

    S. Lorenzl (Hausham, Germany)

    Objective: To evaluate possible risk factors for the development of Progressive Supranuclear Palsy (PSP). Background: Risk factors for the development of neurodegenerative brain disorders are…
  • 2017 International Congress

    A PSP-like phenotype accompanies rapidly progressive dementia

    M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)

    Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley